Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - tacrolimus monohydrate, quantity: 0.51 mg (equivalent: tacrolimus, qty 0.5 mg) - capsule - excipient ingredients: dichloromethane; ethanol absolute; hypromellose; magnesium stearate; croscarmellose sodium; lactose; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate - tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - tacrolimus monohydrate, quantity: 5.1 mg (equivalent: tacrolimus, qty 5 mg) - capsule - excipient ingredients: lactose; dichloromethane; croscarmellose sodium; hypromellose; ethanol absolute; magnesium stearate; titanium dioxide; purified water; iron oxide red; gelatin; sodium lauryl sulfate - tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - tacrolimus monohydrate, quantity: 1.02 mg (equivalent: tacrolimus, qty 1 mg) - capsule - excipient ingredients: hypromellose; magnesium stearate; dichloromethane; lactose; ethanol absolute; croscarmellose sodium; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - tacrolimus monohydrate, quantity: 1.02 mg (equivalent: tacrolimus, qty 1 mg) - capsule - excipient ingredients: hypromellose; dichloromethane; lactose; ethanol absolute; magnesium stearate; croscarmellose sodium; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - tacrolimus monohydrate, quantity: 5.1 mg (equivalent: tacrolimus, qty 5 mg) - capsule - excipient ingredients: dichloromethane; lactose; magnesium stearate; croscarmellose sodium; ethanol absolute; hypromellose; titanium dioxide; purified water; iron oxide red; gelatin; sodium lauryl sulfate - tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - tacrolimus monohydrate eqv tacrolimus - capsule, extended release - tacrolimus monohydrate eqv tacrolimus 0.5 mg

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - tacrolimus monohydrate eqv tacrolimus - capsule, extended release - tacrolimus monohydrate eqv tacrolimus 1.0 mg

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - tacrolimus monohydrate eqv tacrolimus - capsule, extended release - tacrolimus monohydrate eqv tacrolimus 5.0 mg

United States - English - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 1 mg in 1 g - tacrolimus ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. tacrolimus ointment is not indicated for children younger than 2 years of age (see boxed warning , warnings and precautions: pediatric use ). tacrolimus ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - tacrolimus monohydrate, quantity: 0.51 mg (equivalent: tacrolimus, qty 0.5 mg) - capsule - excipient ingredients: dichloromethane; lactose; ethanol absolute; magnesium stearate; croscarmellose sodium; hypromellose; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate - tacrolimus is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.